Toggle navigation
Home
Search
Services
Blog
Contact
About
Preventing Retinal Neovascularization with Nrts
Narducy, Kenneth W.
Centaur Pharmaceuticals, Inc., Sunnyvale, CA, United States
Search 16 grants from Kenneth Narducy
Search grants from Centaur Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Project 2: Genomic And Genetic Analysis Of Liver And Kidney Toxicity Of Trichloro
Nuestro Futoro Saludable: The JP Partnership for Healthy Caribbean Latino Youth
Comprehensive Cancer Center Support Grant
CSR:Small:Multi-Layer Support for Virtualizing Heterogeneous Architectures
SBIR PHASE I: Novel Bridgman Growth of Tungsten Bronze Crystals for Emerging Nonlinear Optical Applications
Recently added grants:
Proteomics and model organism humanization to decode human genetics
SimTK: An Ecosystem for Data and Model Sharing in the Biomechanics Community
Role of Tet proteins in epigenetic regulation of embryonic stem cell biology
Analysis tools for quantifying protein conformational landscapes using DEER spectroscopy
Chelator development for improved scandium theranostic agents
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43EY011061-01A1
Application #
2165317
Study Section
Special Emphasis Panel (ZRG1-VISA (01))
Project Start
1996-07-01
Project End
1997-06-30
Budget Start
1996-07-01
Budget End
1997-06-30
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Centaur Pharmaceuticals, Inc.
Department
Type
DUNS #
City
Sunnyvale
State
CA
Country
United States
Zip Code
94085
Comments
Be the first to comment on Kenneth Narducy's grant